← All organizations
Highest phase reached
Phase 3
First clinical trial
Oct 9, 2018Last known activity
Sep 1, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (16 distinct, 12 trials)
Phase 3 (7 own, 0 via acquisition)
Phase 2 (2 own, 0 via acquisition)
Phase 1 (6 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Recent trials (13)
- NCT07050524CollaboratorPhase 2Sep 1, 2025
- NCT06974292OfficialPhase 1May 26, 2025
- NCT06939439CollaboratorPhase 3Dec 1, 2024
- NCT06538883CollaboratorN/AAug 1, 2024
- NCT06051409Overall official - principal investigatorPhase 3Sep 2, 2023
- NCT06051409OfficialPhase 3Sep 2, 2023
- NCT05836805Overall official - principal investigatorPhase 1May 31, 2023
- NCT05515458Overall official - principal investigatorPhase 1Sep 30, 2022
- NCT05515445Overall official - principal investigatorPhase 1Sep 30, 2022
- NCT05346601Overall official - principal investigatorPhase 1Jun 2, 2022
- NCT04540016CollaboratorPhase 1Oct 15, 2020
- NCT04507841CollaboratorPhase 2Jul 1, 2020
- NCT04816123Overall official - principal investigatorPhase 1Oct 9, 2018
Details
- Last known activity
- Sep 1, 2025